Endless Llp
Endless LLP is a Leeds-headquartered UK private equity firm established in 2005, with offices in Leeds, London and Manchester. It identifies Food & Beverage, Industrials, Business Services and Consumer as its principal sectors and describes investment strategies covering family-owned businesses, non-core carve-outs, complex buy-outs and special situations.
What stands out about Endless Llp
Endless LLP publicly describes a UK-focused investment strategy across Food & Beverage, Industrials, Business Services and Consumer. Endless Fund V typically targets businesses with revenue of £50m to £1bn, while Enact Fund III typically targets UK-based businesses with turnover between £10m and £50m and provides hands-on investments up to the value of £10m.[1][2][3][4][7][8]
What does Endless Llp invest in?
Endless LLP is a UK private equity firm established in 2005 and headquartered in Leeds, with offices in Leeds, London and Manchester. Companies House lists ENDLESS LLP as an active limited liability partnership incorporated in England and Wales under company number OC316569. The firm states that it is authorised and regulated by the Financial Conduct Authority under firm reference number 474096.[1][2][10]
Endless states that it invests in companies with clear potential for value development and in complex situations requiring investment of time, skill and capital. Its approach includes committed capital, in-house financial and commercial due diligence, and hands-on operational support; the firm states that many deals are funded without external financing or outsourced due diligence.[4]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Endless Llp?
Owners considering Endless should establish which fund would pursue the opportunity and how the applicable fund criteria relate to the business’s revenue or turnover. The firm’s stated strategies include family-owned businesses, non-core carve-outs, complex buy-outs and special situations, alongside committed capital, in-house due diligence and hands-on support.
Owners should also clarify ownership percentage, management rollover, follow-on capital, governance rights, leverage, investment horizon and exit approach. The official Funds page does not disclose a universal required ownership percentage, standard leverage parameters or expected investment holding period. The January 2026 acquisition announcement does not disclose purchase price, equity contribution, valuation or ownership percentage.[3][4][7]
Which fund would pursue the opportunity, and what fund-level criteria and investment amount would apply
What ownership percentage and management rollover would Endless typically seek
May follow-on capital be available for acquisitions, capital expenditure and working capital, and if so, how much
What companies does Endless Llp target?
Endless Fund V is described as a £400m fund typically targeting businesses with revenue of £50m to £1bn. Enact Fund III is described as a £100m fund typically targeting UK-based businesses with turnover between £10m and £50m and providing hands-on investments up to the value of £10m.[4]
Endless identifies Food & Beverage, Industrials, Business Services and Consumer as its principal investment sectors.[5]
Endless and Enact describe their strategy as focused on UK businesses and the UK mid-market. The firm operates from Leeds, London and Manchester.[4]
The public sources identify buyouts, carve-outs, family-owned business investments and special situations as transaction types. A February 2025 announcement states that Karnova Food Group was created through Endless’ acquisition and integration of Yorkshire Premier Meat and Smithfield Murray in 2022 and 2023.[3][9]
Publicly identified investments and businesses associated with Endless include Anochrome Group, GEO Specialty Chemicals UK Ltd., Waddington Europe, Hovis Group Limited and Karnova Food Group. Anochrome operates across six facilities in the UK, Poland and the Czech Republic and serves industrial, automotive, construction, motorsport, renewables and aerospace markets. Karnova was created through the acquisition and integration of Yorkshire Premier Meat and Smithfield Murray.[6][7][8][9]
Endless acquired Anochrome Group in June 2026 through a management buy-out from long-standing family ownership. In January 2026, the Enact Fund acquired GEO Specialty Chemicals UK Ltd. from CPS Performance Materials Group and acquired Waddington Europe in a corporate carve-out.
Endless sold Hovis Group Limited to Associated British Foods plc on 9 July 2026 after Competition and Markets Authority clearance on 16 June 2026. It sold Karnova Food Group to OSI UK in February 2025.[6][7][8][9]
What is not clear from Endless Llp's public investment criteria?
The official Funds page does not disclose a universal minimum equity cheque, required ownership percentage, standard leverage parameters or expected investment holding period for all Endless or Enact transactions.
The official announcement concerning the January 2026 GEO Specialty Chemicals UK and Waddington Europe acquisitions does not disclose purchase price, equity contribution, valuation or ownership percentage for either transaction. The official July 2026 Hovis sale announcement identifies the buyer and regulatory clearance but does not disclose transaction consideration or valuation.[4][7][8]
Questions to ask when evaluating Endless Llp as a buyer or investment partner
Which fund would pursue the opportunity, and what fund-level criteria and investment amount would apply?
What ownership percentage and management rollover would Endless typically seek?
May follow-on capital be available for acquisitions, capital expenditure and working capital, and if so, how much?
What is the expected investment horizon and exit approach?
Can Endless provide comparable transaction references, including completed deal timelines and financing structures?
How would the firm balance founder liquidity, management incentives and future governance?
Sources & research notes
- Official website / firm overview
- Identity / organization record
- Services / capabilities
- Investment approach
- Industry / market focus
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.